CIK: 0001744967 · Show all filings
Period: Q1 2021 (← Previous) (Next →)
Filing Date: May 18, 2021
Total Value ($000): $542,203 (100.0% shares, 0.0% debt)
| Ticker | Issuer | Shares | Value ($000) | % | Est. Cost | Unrealized | Class | CUSIP |
|---|---|---|---|---|---|---|---|---|
| NKTX | Nkarta, Inc. | 2,034,703 | $66,942 | 12.3% | $29.47 | +62.1% | COM | 65487U108 |
| — | Chinook Therapeutics Inc | 3,168,388 | $49,237 | 9.1% | $15.86 | — | COM | 16961L106 |
| — | Forma Therapeutics Holdings, Inc. | 1,565,529 | $43,866 | 8.1% | $44.76 | — | COM | 34633R104 |
| — | Instil Bio Inc | 1,554,025 | $38,975 | 7.2% | $25.08 | — | COM | 45783C101 |
| — | Sutro BioPharma Inc | 1,675,579 | $38,136 | 7.0% | $8.61 | — | COM | 869367102 |
| NVAX | Novavax, Inc. | 198,600 | $36,008 | 6.6% | $117.44 | +69.7% | Call | 670002401 |
| ACRS | Aclaris Therapeutics, Inc. | 1,022,612 | $25,770 | 4.8% | $1.36 | +1336.7% | COM | 00461U105 |
| — | Bolt Biotherapeutics, Inc | 737,459 | $24,270 | 4.5% | $32.91 | — | COM | 097702104 |
| — | Allakos Inc | 146,259 | $16,788 | 3.1% | $51.45 | — | COM | 01671P100 |
| — | Intercept Pharmaceuticals Inc | 640,688 | $14,787 | 2.7% | $64.16 | — | COM | 45845P108 |
| — | Syros Pharmaceuticals Inc | 2,189,199 | $14,769 | 2.7% | $7.95 | — | COM | 87184Q107 |
| — | Iveric Bio, Inc. | 2,372,476 | $14,664 | 2.7% | $5.74 | — | COM | 46583P102 |
| — | Springworks Therapeutics Inc | 169,852 | $12,496 | 2.3% | $21.68 | — | COM | 85205L107 |
| TERN | Terns Pharmaceuticals, Inc | 497,555 | $10,946 | 2.0% | $21.92 | 0.0% | COM | 880881107 |
| — | Allakos Inc | 83,000 | $9,527 | 1.8% | $51.45 | — | Call | 01671P100 |
| — | Decibel Therapeutics Inc | 826,422 | $9,388 | 1.7% | $11.36 | — | COM | 24343R106 |
| — | Verona Pharma PLC. | 1,111,112 | $9,289 | 1.7% | $6.18 | — | SPONS ADS | 925050106 |
| — | CureVac N.V. | 95,318 | $8,718 | 1.6% | $46.55 | — | COM | N2451R105 |
| — | Viracta Therapeutics Inc | 831,625 | $7,693 | 1.4% | $9.25 | — | COM | 92765F108 |
| — | Aeglea BioTherapeutics, Inc. | 883,720 | $6,999 | 1.3% | $9.25 | — | COM | 00773J103 |
| — | Atreca Inc | 396,835 | $6,083 | 1.1% | $17.99 | — | COM | 04965G109 |
| — | BCTG Acquisition Corp | 500,000 | $5,560 | 1.0% | $10.36 | — | COM | 05492W103 |
| NVAX | Novavax, Inc. | 30,160 | $5,468 | 1.0% | $117.44 | +69.7% | COM | 670002401 |
| EQ | Equillium, Inc. | 764,403 | $5,465 | 1.0% | $8.10 | -11.4% | COM | 29446K106 |
| — | Jiya Acquisition Corp | 507,041 | $4,989 | 0.9% | $1009.74 | — | COM | 47760M102 |
| — | Avadel Pharmaceuticals PLC | 549,250 | $4,965 | 0.9% | $7.17 | — | SPONS ADR | 05337M104 |
| — | Kronos Bio Inc | 166,250 | $4,866 | 0.9% | $29.87 | — | COM | 50107A104 |
| EYPT | Eyepoint Pharmaceuticals Inc | 450,000 | $4,572 | 0.8% | $11.25 | 0.0% | COM | 30233G209 |
| RYTM | Rhythm Pharmaceuticals Inc | 201,046 | $4,276 | 0.8% | $17.90 | +62.0% | COM | 76243J105 |
| — | Alpine Immune Sciences Inc | 399,190 | $4,231 | 0.8% | $8.79 | — | COM | 02083G100 |
| — | Kala Pharmaceuticals Inc | 601,162 | $4,052 | 0.7% | $8.83 | — | COM | 483119103 |
| — | Vistagen Therapeutics Inc | 1,831,490 | $3,901 | 0.7% | $1.96 | — | COM | 92840H202 |
| — | Albireo Pharma, Inc. | 100,000 | $3,525 | 0.7% | $33.37 | — | COM | 01345P106 |
| IMCR | Immunocore Holdings Limited | 80,000 | $3,406 | 0.6% | $42.58 | — | SPONS ADS | 45258D105 |
| — | BCLS Acquisition Corp | 300,000 | $3,171 | 0.6% | $11.14 | — | COM | G0904B105 |
| — | Consonance HFW Acquisition Co | 300,000 | $2,928 | 0.5% | $10.47 | — | COM | G2445M129 |
| RCKT | Rocket Pharmaceuticals Inc | 63,770 | $2,829 | 0.5% | $19.67 | +179.1% | COM | 77313F106 |
| — | Odonate Therapeutics Inc | 700,421 | $2,395 | 0.4% | $14.27 | — | COM | 676079106 |
| — | Lifesci Acquisition II Corp | 200,000 | $2,028 | 0.4% | $10.67 | — | COM | 53229E103 |
| — | Allovir, Inc | 82,336 | $1,927 | 0.4% | $27.50 | — | COM | 019818103 |
| BNTX | BioNTech SE | 10,795 | $1,179 | 0.2% | $69.21 | — | SPONS ADS | 09075V102 |
| — | NGM Biopharmaceuticals, Inc. | 18,225 | $530 | 0.1% | $19.73 | — | COM | 62921N105 |
| — | Catabasis Pharmaceuticals Inc | 150,000 | $434 | 0.1% | $4.37 | — | COM | 14875P206 |
| — | Amarin Corp PLC | 25,000 | $155 | 0.0% | $4.00 | — | SPONS ADR NEW | 023111206 |